Trials / Sponsors / Pharmexa A/S
Pharmexa A/S
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma. Carcinoma, Hepatocellular | Phase 2 | 2006-11-01 |
| Terminated | GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer Advanced Unresectable Pancreatic Cancer | Phase 3 | 2006-06-01 |